semaglutide and ibs IBS: Weight Loss Without Gut Complications Association of pharmacotherapy with all-cause
Description
The standard eligibility criteria require either a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related health condition
Ro sells FDA-approved brand-name drugs: Wegovy, Zepbound, cash-pay Ozempic, and a new oral orforglipron option added in April 2026
However, sustained weight loss is difficult for many patients
Semaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity by improving blood sugar control and promoting weight loss
